Palliative care integration and end-of-life outcomes in veterans with metastatic colon cancer. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not include a ...
Results show that the first-line antidiabetic drug metformin and the second-line sodium glucose co-transporter-2 (SGLT-2) inhibitors lower the risk of dementia and AD. Sulfonylureas significantly ...
Final results of phase Ib/II study of durvalumab and guadecitabine in advanced clear cell renal cell carcinoma (ccRCC) and biomarker analysis. This is an ASCO Meeting Abstract from the 2023 ASCO ...